Press release
Hepatitis B Diagnostic Test Market to Make Great Impact In Near Future by 2026
Hepatitis B is an infectious disease associated with the inflammation of the liver. Hepatitis B infection is caused due to the Hepatitis B virus (HBV) transmitted from one person to other through infectious blood, semen and other body fluids. Hepatitis B infection can be acute and it may develop into chronic infection if not diagnosed and treated at an early stage. Chronically infected Hepatitis B patients eventually develop liver cirrhosis, hepatocellular carcinoma (liver cancer), fulminant hepatitis B (autoimmune disorder) or suffer from liver failure requiring liver transplant and can even result in death. In 2014, out of the 360 Mn people infected with hepatitis B worldwide, around 1 Mn people died of the disease or other complications associated with it. However, there is a significant decrease in incidence of hepatitis B after introduction of hepatitis B vaccine. Diagnosis of HBV is achieved by performing several tests for serological markers of HBV such as HBsAg, anti-HBs antibodies, HBeAg, anti-HBe antibodies and anti-HBV core antibodies. Currently, nucleic acid testing for HBV DNA is used to detect the hepatitis B viral load. The diagnosis of hepatitis B involves collection of blood samples followed by the detection of viral antigens and antibodies in either serum or plasma.
Hepatitis B Diagnostic Test Market: Drivers and Restraints
In vitro diagnostics is the vital market for the hepatitis B diagnostic test as the serological markers from blood are tested outside the body in the laboratory. Increasing prevalence and incidence of hepatitis B worldwide and multitude of available tests are the major drivers for the increasing growth of global hepatitis B diagnostic test market. Increasing public awareness and understanding of viral hepatitis, promotion of wider access to monitoring and screening procedures by several countries as a part of national program and introduction of evidence based policies are anticipated to aid the growth of global hepatitis B diagnostic tests market. However, complexity of clinical management and lack of coordination between clinicians and laboratory personnel to decide choice of assay employing appropriate hepatitis B diagnostic test will remain some of the major restraints for the global hepatitis B diagnostic test market.
Request free sample Report: http://www.futuremarketinsights.com/reports/sample/rep-gb-1332
Hepatitis B Diagnostic Test Market: Segmentation
The global hepatitis B diagnostic tests market is classified on the basis of test type, technique end use and geography.
Based on test type, the global hepatitis B diagnostic test market is segmented into the following:
Hepatitis B surface antigen test (HBsAg)
Anti-hepatitis B surface antibody test
Hepatitis B core antigen test (HBcAb)
Anti-hepatitis B core antibody test
HBV DNA test
Others
Based on techniques, the global hepatitis B diagnostic test market is segmented into the following:
PCR
Radioimmunoassay (RIA)
Enzyme-linked immunosorbent assay (ELISA)
Others
Based on end use type, the global hepatitis B diagnostic test market is segmented into the following:
Hospitals
Diagnostic centers
Clinics
Hepatitis B Diagnostic Test Market: Overview
More than 13 immunoassays are available for the diagnosis of hepatitis B at an early stage. They can also be used to distinguish acute and chronic hepatitis B infections. Global market for HBsAg test is expected to drive the greater revenue generation as it the preliminary test for the detection of HBV in the blood of infected person and also the test is ordered for many of the blood donors prior to blood donation.
Request for TOC: http://www.futuremarketinsights.com/toc/rep-gb-1332
Hepatitis B Diagnostic Test Market: Regional Overview
Geographically, the global hepatitis B diagnostic tests market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America is expected to be the key region in global hepatitis diagnostic tests market followed by Asia-Pacific and Europe. Availability of good reimbursement policies for diagnostic tests in many of the high income countries in Europe is expected to keep up the market for hepatitis B diagnostic testsin nearest future.
Hepatitis B Diagnostic Test Market: Key Players
Some of the key players providing diagnostic tests for hepatitis B are MedMira Inc, Abbott Laboratories, Inovio pharmaceuticals Inc., Siemens Healthcare GmbH, Innovita biological technology Co. Ltd., Assure Tech. (Hangzhou) Co. Ltd., Nantong Diagnos biotechnology Co. Ltd., Blue Cross Bio-Medical (Beijing) Co. Ltd., BioGenex., Abnova Corporation etc.
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature.
Mr. Sudip saha
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hepatitis B Diagnostic Test Market to Make Great Impact In Near Future by 2026 here
News-ID: 329091 • Views: …
More Releases from FMI Reports
Research report covers the Triallyl Isocyanurate Market Growth, 2016-2026
Future Market Insights has announced the addition of the “Triallyl Isocyanurate Market: Global Industry Analysis and Opportunity Assessment 2016-2026" report to their offering.
Triallyl isocyanurate is used as a cross linking in the manufacture of agrochemicals, flame retardants and synthetic rubbers. It is synthesized by gradually adding cyanuric chloride to excess of alcohol or allyl chloride in the presence concentrated aqueous phase. For various applications, triallyl isocyanurate can be…
Structured Cabling Market Growth and Segments,2016-2026
Future Market Insights has announced the addition of the “Structured Cabling Market: Global Industry Analysis and Opportunity Assessment 2016-2026" report to their offering.
Structured cabling system is defined as the combination of set of cables & associated hardware used to provide comprehensive telecommunication infrastructure to various management systems, this telecommunication infrastructure enables the transmission of data, voice & video signal through a communication network from one point to other…
Polyetheramine Market, 2016-2026 by Segmentation: Based on Product, Based on App …
Future Market Insights has announced the addition of the “Polyetheramine Market: Global Industry Analysis and Opportunity Assessment 2016-2026" report to their offering.
Polyetheramines are typically the curing agents which contain polyether and amine moieties, are majorly used to increase toughness, flexibility, hydrophobicity or hydrophilicity of the end-products. Polyetheramines are used for a range of applications including polyurea, epoxy curing and polyamides in a range of coatings. Polyetheramines are also…
Immunochemistry Analyzer Market Regulations and Competitive Landscape Outlook to …
Future Market Insights has announced the addition of the “Immunochemistry Analyzer Market: Global Industry Analysis and Opportunity Assessment 2015-2025" report to their offering.
Immunochemistry analyzer are becoming more and more popular in the global clinical chemistry and immunoassay as these are proved to be very effective tool to diagnose cancer, hepatitis, illegal drugs, fertility problems, sodium levels, endocrine function, and the detection of blood clots.
There are approximately more than 180,000 immunochemistry…
More Releases for Hepatitis
Is Hepatitis A Vaccine Required?
Hepatitis A Vaccine Market describes its growth, size, share, Forecast and trends to 2025
Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.
Two types of HAV vaccines are currently available internationally:
1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available…
Hepatitis Drugs Market Is Growing Due to Increasing R&D Investments on Hepatitis …
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market.
Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market
Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest…
Hepatitis B Therapeutics Market Is Driven by Rising Incidence of Hepatitis B In …
Hepatitis B is a life threatening liver infection caused by hepatitis B virus. Adults who get affected by hepatitis B virus for a short time and then get cured is known as acute hepatitis B. Infection that lasts for a long time is known as chronic hepatitis B. Vaccine is the most preferred choice of doctors and physicians to protect people from the disease. The vaccine prevents the infection and…
Hepatitis E Hyperendemicity to Drive Hepatitis E Diagnostic Tests Market Growth
Global Hepatitis E Diagnostic Tests Market: Snapshot
The growing incidence of hepatitis E, a liver disease caused by infection due to the virus hepatitis E virus (HEV), is a leading cause of morbidity and mortality worldwide. There is increasing prevalence of hepatitis E in resource-limited region, such as various countries of Asia Pacific. The people of these regions suffer with frequent water contamination and have limited access to sanitation and hygiene,…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Hepatitis C Drug Pipeline Analysis
“Hepatitis C Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles being developed for the treatment of Hepatitis C. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. Insight for each…
